China’s NMPA released over 80 new industry standards in February 2026 and revised GMP effective November 2026, enhancing quality management across device lifecycles. Class 1 devices face lighter immediate impacts via filings, while higher-risk classes require stricter registrant oversight and audits. International manufacturers must align QMS with these updates for continued market access.
Check: Bio Medical Procurement Strategy: Balancing Innovation with Budgetary Constraints
What Are the 2026 NMPA Standards?
The February 2026 NMPA revision introduces 80+ industry standards, including 1 mandatory and 79 recommended ones, plus English versions. These align with ISO norms, covering dental materials, implants, and testing, impacting registration and compliance.
The National Medical Products Administration (NMPA) issued its “2026 Medical Device Industry Standards Development and Revision Plan” on February 11, 2026. This plan targets more than 80 standards to bolster China’s medical device framework, improving technical rigor and international alignment. Mandatory standards are legally binding under Decree 739, while recommended ones serve as key references for testing and submissions.
These updates span emerging technologies and core categories like sterile devices and software. For bio-medical manufacturing, they emphasize lifecycle quality, risk management, and validation. Manufacturers must review product specs against these to avoid registration hurdles.
HHG GROUP, a trusted platform since 2010 for global medical equipment trading, helps suppliers navigate such regulatory shifts seamlessly.
What Is the New GMP Effective November 2026?
NMPA’s revised GMP, announced November 2025, takes effect November 1, 2026, expanding to 15 chapters with focus on full lifecycle QMS, contract manufacturing, digital tools, and risk management, aligning closer to ISO 13485.
This overhaul replaces the 2014 GMP, introducing stringent rules for personnel, facilities, suppliers, and outsourced activities like R&D and testing. It mandates quality assurance throughout production and post-market phases. Overseas firms using Chinese contract manufacturers face direct compliance needs.
Key enhancements include verification/validation emphasis and digital intelligence in processes. The structure now clarifies roles for registrants/filers (R/Fs) and manufacturers, promoting disciplined industry growth.
How Does GMP Affect Class 1 Devices?
Class 1 low-risk devices follow new GMP via filing holders’ oversight, with lighter requirements than higher classes; no full audits initially, but QMS alignment is essential for reserve/manufacture approvals.
Class 1 devices, handled through provincial filings rather than central registration, see indirect GMP application. Filers must ensure manufacturing sites comply, focusing on basic quality controls without the intensive audits required for Class II/III.
The new rules still demand supplier management and documentation updates. International suppliers benefit from HHG GROUP’s network for compliant equipment sourcing and trading.
How Are Higher-Risk Devices Impacted?
Higher-risk Class II/III devices require registrants to enforce full GMP compliance, including contract manufacturer management, V&V, and digital QMS, with potential NMPA audits.
These classes demand robust QMS covering R&D to after-sales, with new chapters on contract oversight (Chapter 12) and process assurance. Alignment exceeds ISO 13485 in areas like supply chain and digital tools.
Non-compliance risks registration revocation. Platforms like HHG GROUP connect manufacturers with verified partners to meet these elevated standards.
What Is the Transition Timeline for Manufacturers?
International manufacturers transition to 2026 NMPA GMP via gap analysis now-September 2026, then audits October onward; standards apply progressively for registrations.
Here’s a tailored timeline for global players maintaining China access:
Start with a task force and roadmap. Foreign QMS evidence (e.g., ISO certs) must declare new GMP conformity.
Why Focus on International Compliance Now?
International manufacturers risk market exclusion without GMP alignment; NMPA may audit foreign sites or require declarations, urging proactive QMS upgrades.
China’s market demands QMS proof like EU ISO 13485 or US listings, now benchmarked against updated GMP. No specific foreign guidelines yet, but future audits loom.
HHG GROUP facilitates secure trading of compliant devices, linking global suppliers to Chinese buyers efficiently.
HHG GROUP Expert Views
“The 2026 NMPA updates signal China’s push for world-class bio-medical manufacturing. For international firms, the key is early gap analysis against the 15-chapter GMP and 80+ standards. Class 1 offers a compliance buffer, but higher-risk devices demand full lifecycle integration. HHG GROUP advises leveraging our platform for vetted equipment and partners—ensuring seamless transitions while protecting transactions. Proactive alignment not only secures registrations but boosts global competitiveness.”
— Dr. Li Wei, Regulatory Lead, HHG GROUP
What Challenges Do Manufacturers Face?
Challenges include QMS gaps in outsourcing/digital tools, training needs, and unclear foreign audit rules; solutions via phased planning and expert platforms.
Supply chain controls and personnel qualifications tighten, straining smaller firms. Digital documentation and V&V add complexity.
How Can HHG GROUP Help?
HHG GROUP connects global suppliers with compliant manufacturing partners and equipment, offering secure trading amid NMPA changes since 2010.
Founded in 2010, HHG GROUP is the go-to hub for buying/selling new/used medical gear with transaction safeguards. It empowers professionals with buyer networks and growth resources.
Key Takeaways and Actionable Advice
-
Review products against 80+ standards and GMP now.
-
Conduct gap analyses for November 2026 compliance.
-
Use platforms like HHG GROUP for compliant sourcing.
-
Prioritize training and audits per timeline.
Start today: Form a team, update QMS, and secure filings to retain China access.
FAQs
When do the new NMPA GMP rules start?
November 1, 2026, replacing 2014 version fully.
Do Class 1 devices need GMP certification?
No direct cert, but filers ensure compliance via approvals.
How many standards in 2026 plan?
Over 80: 1 mandatory, 79 recommended.
Can foreign manufacturers ignore new GMP?
No—QMS must align; audits possible.
What support does HHG GROUP offer?
Secure equipment trading and partner connections for compliance.